Back to funds
View filing
TANG CAPITAL MANAGEMENT LLC
hedge fundUpdated 27 days agoManaged by Tang Capital Management Llc • Latest filing Q2 2026
Portfolio value
$2.2B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
62.7%
Weight of largest holdings
Annualized return
44.1%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $671.1M |
| Q2 2023 | $679.3M |
| Q3 2023 | $708.7M |
| Q4 2023 | $1.1B |
| Q1 2024 | $960.4M |
| Q2 2024 | $981.9M |
| Q3 2024 | $1.4B |
| Q4 2024 | $1.5B |
| Q1 2025 | $1.8B |
| Q2 2025 | $2B |
| Q3 2025 | $2.6B |
| Q4 2025 | $2B |
| Q1 2026 | $2B |
| Q2 2026 | $2.2B |
Top holdings
41 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A AUPH AURINIA PHARMACEUTICALS INC | $221.4M | 13.04M | 10.05% | Added(+6.7%) |
| 2 | S SYRE SPYRE THERAPEUTICS INC | $168M | 1.89M | 7.63% | Unchanged |
| 3 | M MIRM MIRUM PHARMACEUTICALS INC | $144.7M | 1.24M | 6.57% | Unchanged |
| 4 | K KNSA KINIKSA PHARMACEUTICALS INTL | $144.5M | 2.26M | 6.56% | Unchanged |
| 5 | C CELC CELCUITY INC | $137.5M | 1.31M | 6.25% | Added(+25.2%) |
| 6 | C CORT CORCEPT THERAPEUTICS INC | $130.4M | 1.50M | 5.92% | Unchanged |
| 7 | ? N/A PTC THERAPEUTICS INC | $122.4M | 1.50M | 5.56% | Unchanged |
| 8 | G GLPGF LAKEFRONT BIOTHERAPEUTICS NV | $113.5M | 3.79M | 5.16% | Unchanged |
| 9 | C CAPR CAPRICOR THERAPEUTICS INC | $98.7M | 4.10M | 4.48% | Added(+20.6%) |
| 10 | T TARS TARSUS PHARMACEUTICALS INC | $98.7M | 1.57M | 4.48% | Added(+31.9%) |
| 11 | S SPY STATE STR SPDR S&P 500 ETF T | $91.9M | 123.0K | 4.17% | Trimmed(-26.8%) |
| 12 | A ADI ANAPTYSBIO INC | $89.8M | 1.33M | 4.08% | Unchanged |
| 13 | I IMCR IMMUNOCORE HLDGS PLC | $84.1M | 2.65M | 3.82% | Unchanged |
| 14 | C CMPS COMPASS PATHWAYS PLC | $70.8M | 5.00M | 3.21% | Added(+24.9%) |
| 15 | A ANIP ANI PHARMACEUTICALS INC | $58.6M | 707.5K | 2.66% | Unchanged |
| 16 | B BNTX BIONTECH SE | $43.7M | 470.0K | 1.99% | Unchanged |
| 17 | ? N/A COMPASS THERAPEUTICS INC | $39.4M | 17.99M | 1.79% | Added(+7.2%) |
| 18 | ? N/A PRECIGEN INC | $36.6M | 6.42M | 1.66% | Unchanged |
| 19 | V VRDN VIRIDIAN THERAPEUTICS INC | $32.9M | 1.79M | 1.50% | Unchanged |
| 20 | ? N/A NUVECTIS PHARMA INC | $28.5M | 1.55M | 1.29% | — |